Literature DB >> 1578456

Decreased interleukin 1 activity released from circulating monocytes of patients with familial Mediterranean fever during in vitro stimulation by lipopolysaccharide.

M Rozenbaum1, R Katz, I Rozner, S Pollack.   

Abstract

Familial Mediterranean fever (FMF) is an inherited disorder of unknown etiology characterized by recurrent episodes of serous membrane inflammation. Interleukin 1 (IL-1) is a mediator of inflammatory processes. We hypothesized that IL-1 may play a role in acute attacks of FMF. Thus we tested IL-1 production by monocytes derived from patients with FMF. Nine patients were tested during acute attacks and 9 were asymptomatic when tested. Monocytes derived from peripheral blood of patients and controls were stimulated with lipopolysaccharide (LPS) and IL-1 activity in the supernatant was tested using a T helper cell line (D10-4G.1). IL-1 secretion during acute attacks was decreased whereas IL-1 production in asymptomatic patients was comparable to healthy controls. Followup of symptomatic patients during the recovery period revealed normalization of IL-1 secretion. Addition of indomethacin (prostaglandin E2 inhibitor) to LPS stimulated monocytes did not change IL-1 activity in patients or healthy controls. We conclude that in vitro IL-1 activity in patients with FMF is associated with the intensity of the inflammatory process.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1578456

Source DB:  PubMed          Journal:  J Rheumatol        ISSN: 0315-162X            Impact factor:   4.666


  8 in total

Review 1.  Type I IFN-mediated regulation of IL-1 production in inflammatory disorders.

Authors:  Kristina Ludigs; Valeriy Parfenov; Renaud A Du Pasquier; Greta Guarda
Journal:  Cell Mol Life Sci       Date:  2012-04-24       Impact factor: 9.261

2.  [IL-1 antagonists].

Authors:  I Kötter; G Horneff
Journal:  Z Rheumatol       Date:  2010-09       Impact factor: 1.372

3.  Is Familial Mediterranean Fever a thrombotic disease or not?

Authors:  Atalay Demirel; Tiraje Celkan; Ozgur Kasapcopur; Hulya Bilgen; Alp Ozkan; Hilmi Apak; Nil Arisoy; Inci Yildiz
Journal:  Eur J Pediatr       Date:  2007-04-14       Impact factor: 3.183

4.  Serum soluble interleukin-2 receptor levels in familial Mediterranean fever.

Authors:  E Erken; R Güneşaçar; S Ozbek; K Konca
Journal:  Ann Rheum Dis       Date:  1996-11       Impact factor: 19.103

Review 5.  Chronic inflammation in FMF: markers, risk factors, outcomes and therapy.

Authors:  Ilan Ben-Zvi; Avi Livneh
Journal:  Nat Rev Rheumatol       Date:  2010-11-09       Impact factor: 20.543

6.  Continuity of cytokine activation in patients with familial Mediterranean fever.

Authors:  Sait Bagci; Bulent Toy; Ahmet Tuzun; Yuksel Ates; Murat Aslan; Ali Inal; Mustafa Gulsen; Necmettin Karaeren; Kemal Dagalp
Journal:  Clin Rheumatol       Date:  2004-05-01       Impact factor: 2.980

7.  Does immune activation continue during an attack-free period in familial Mediterranean fever?

Authors:  U Musabak; A Sengul; C Oktenli; S Pay; Z Yesilova; L Kenar; S Y Sanisoglu; A Inal; A Tuzun; A Erdil; S Bagci
Journal:  Clin Exp Immunol       Date:  2004-12       Impact factor: 4.330

8.  Melatonin and its day and night rhythm of alterations in familial mediterranean Fever: a brief research letter.

Authors:  Ugur Musabak; Guldem Kilciler; Ahmet Uygun; Murat Kantarcıoglu; Zulfukar Polat; Rahsan I Sagkan; Sait Bagci
Journal:  Open Rheumatol J       Date:  2011-02-04
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.